Clinilabs

Clinilabs, known by its slogan, "The CRO for CNS", is positioned as a leader in the biotechnology sector, particularly specializing in central nervous system (CNS) drug, device, and technology development. Established in 2000 and headquartered in the United States, Clinilabs stands out as a global, full-service contract research organization (CRO).

The company excels with a proven track record, boasting over 800 completed CNS clinical trial awards and more than 30 marketed products addressing over 25 indications. This extensive experience across Phase 1-3 trials highlights their deep expertise in managing complex neurotherapeutic clinical trials, accelerating treatments for psychiatric, neurological, substance use, and both rare and ultra-rare CNS disorders.

However, there is no record of recent investments, which might prompt discussions regarding the necessity of external funding to sustain its pioneering role in the CNS arena.